Cargando…
Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
During the past decades, drugs targeting transforming growth factor-β (TGFβ) signaling have received tremendous attention for late-stage cancer treatment since TGFβ signaling has been recognized as a prime driver for tumor progression and metastasis. Nonetheless, in healthy and pre-malignant tissues...
Autores principales: | Chen, Jitang, Ding, Ze-yang, Li, Si, Liu, Sha, Xiao, Chen, Li, Zifu, Zhang, Bi-xiang, Chen, Xiao-ping, Yang, Xiangliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738904/ https://www.ncbi.nlm.nih.gov/pubmed/33391538 http://dx.doi.org/10.7150/thno.51383 |
Ejemplares similares
-
Hyperbaric Oxygen Boosts PD‐1 Antibody Delivery and T Cell Infiltration for Augmented Immune Responses Against Solid Tumors
por: Liu, Xin, et al.
Publicado: (2021) -
Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy
por: Xiong, Yuxuan, et al.
Publicado: (2022) -
Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with stiff nanogels
por: Li, Zheng, et al.
Publicado: (2023) -
Colloidal hydroxyethyl starch for tumor-targeted platinum delivery
por: Xiao, Chen, et al.
Publicado: (2018) -
Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling
por: Wu, Yu, et al.
Publicado: (2018)